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Cogan’s Syndrome (CS) is a disease affecting young
adults and consists of episodes of acute interstitial
keratitis with vestibuloauditory dysfunction. This
syndrome was originally described in 1945 by Cogan as a
disorder of the eyes and ears, characterized by
nonsyphilitic interstitial keratitis with deafness. Sporadic
reports showing the development of vasculitis in patients
with eye and ear disease have been published over the last
30 years. When ocular signs, in addition to interstitial
keratitis, are present, the syndrome is referred to as
atypical Cogan’s Syndrome. Although cases of scleritis and
posterior scleritis accompanying interstitial keratitis have
been reported in the literature (1, 2), iridocyclitis is
extremely rare (3). Presented below is a report of an
atypical CS with iridocyclitis, and a review of the
literature to familarize doctors with this unusual but
treatable disorder.
A 17-year-old man was admitted to hospital on June
25, 1996, suffering from deafness, a burning sensation
in the eyes, redness of the eyes and blurring of the vision.
He had been well until a week before, when he began to
experience wheezing. He was admitted to a local hospital,
but deafness and blurring of the vision were added to the
clinical picture and the patient was referred to our
hospital.
An ophthalmologic examination revealed that visual
acuity was 0.2 bilaterally. Conjunctival hyperemia and
mild ciliary injection, and bilateral interstitial keratitis, as
well as iridocyclitis with three positive cells in the anterior
chamber were detected with a slit lamp examination.
Intraocular pressures were within the normal limits.
Ophthalmoscopy at the acute stage was not possible
because of anterior segment reaction. There was no
history of Behçet’s disease or other vasculitic disorders.
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On physical examination, bilateral deafness was
detected. Rinne tests were negative and auditory-evoked
potential was not detected in either ear. Bilateral total
deafness was detected through pure tone audiometry. A
complete blood count and urinanalysis were found to be
normal. Serologic tests for syphilis were negative.
Electroencephalography,
cranial
computerized
tomography and visual-evoked potentials were also
normal. Echocardiography revealed that the heart was
hyperdynamic.
High-dose prednisolone (100mg/day) was initiated.
The patient also received topical prednisolone eye drops 8
times daily and cycloplegics as well as warm compresses,
3 times daily. The iridocyclitis was completely resolved
within ten days. After three months, the interstitial
keratitis showed significant improvement and visual
acuity increased bilaterally by 4 to 5 lines.
Ophthalmoscopy did not reveal any abnormality in either
eye. In general, good progress was observed. However,
total deafness remained a major problem, showing no
improvement despite therapy.
CS was first described by Cogan in 1945. It is
characterized by nonsyphilitic interstitial keratitis and
vestibuloauditory dysfunction. The average age for the
onset of the disease is twenty-five, but it has been
reported in patients between 4 and 63 years of age (4).
Our patient was 17 years old and did not show any clinical
or laboratory evidence of syphilis.
The primary ocular manifestation of typical CS is
chronic bilateral interstitial keratitis. Keratitis is
manifested by patchy infiltrates of the deep corneal
strome. Atypical forms of CS have been described with
bilateral posterior scleritis (1). However, iridocyclitis
occuring as the accompanying ocular lesion is extremely
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rare. Klausen et al. (3) reported such a case in 1992 and,
to our knowledge, ours is the second case with
iridocyclitis accompanying interstitial non-syphilitic
keratitis. The visually evoked potential (VEP) may be
normal, as was pointed out by Magni et al. (5). Our
patient also had a normal VEP.
Vestibuloauditory involvement typically begins
unilaterally with hearing loss and tinnitus, accompanied
by vertigo, nausea, vomiting, ataxia and nystagmus (6).
Vestibuloauditory dysfunction may occur concomitantly
with the visual symptoms or they may precede or follow
the onset of visual symptoms by as much as three
months. Although hearing loss is complete in CS,
sometimes it may be preceded by exacerbations and
remissions. Similar involvement of the other ear often
follows within the next few weeks or months, leaving the
patient permanently deaf. Hearing tests in the early
stages of the disease show cochlear involvement. Caloric
tests usually produce negative results. In some patients
with CS, small calcified obliterations were detected with
computerized tomography and a high signal inside the
membranous labyrinth was observed on T1 weighted
magnetic resonance images (7). Cranial computerized
tomography in this case was normal.
A review of 109 cases revealed that 72 percent of
patients had clinical manifestations beyond the
ophthalmic, auditory and vestibular signs (8). The most
important systemic complication of CS is aortic valve
involvement with acute aortitis in up to 10 percent of
patients. In our case, echocardiography showed that the
heart was hyperdynamic. Other systemic complications
are unexplained fever (34%), heart disease (25%),
gastrointestinal
signs
(25%),
musculoskeletal
involvement (23%), hypertension (9%) and cerebral
artery occlusion (5%). The patient in this case did not
have these complications.
The pathogenesis of CS has not yet been explored.
Autopsy findings revealed aortitis with involvement of all
layers of the aorta, secondary heart and kidney infarction,
and necrotizing angiitis in the dura, brain, gastrointestinal
tract, spleen and kidneys as well as focal degeneration of
arterial walls at the extremities and lymphocyte and
plasma cell infiltration in deep layers of the cornea (9).

Ishii et al. reported that the ligamentum spirale cochlea
was infiltrated with plasma cells and lymphocytes in CS;
endolymphatic hydrops in the cochlea, collapse of the
saccule and fibrosis in the posterior semicircular canal
were also described by the same authors (10).
The presence of lymphocytes and plasma cells in the
conjunctiva and cornea suggests immune-mediated
damage. Anterior uveitis, detected in this case, may also
suggest a possible immune mechanism. However, the
exact mechanism has yet to be revealed. CS has been
detected in a patient with antiphospholipid antibodies
(11). CS associated with Crohn’s disease has also been
reported; immune-mediated mechanisms again were
thought to play a major pathogenic role (12). An
interesting clinical entity, autoimmune sensorineural
hearing loss, is also believed to be closely related to
Cogan’s syndrome (13, 14, 15).
There is no effective therapy for CS. As for the
management of keratitis, topical steroids are beneficial.
The treatment of uveitis, if present, is not different from
the classical uveitis management, involving topical
steroids, mydriatics and cycloplegics as well as warm
compresses whenever necessary. Our case also responded
well to such therapy. Systemic corticosteroids are
indicated in the early treatment of acute deafness in CS.
Therefore, one to two mg/kg of oral prednisone may be
administered for 2 to 4 weeks. If hearing is improved by
this treatment, corticosteroids should be continued to be
taken on alternate days. Hearing did not improve in our
case and there are other similar examples of such in the
literature (16).
Here a case of atypical CS has been described and the
relevent literature reviewed. The importance of early
diagnosis and treatment to prevent hearing loss have
been emphasized once more.
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